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taking over from its first Director, Greg Schultz, the Soci-
ety was three years old and still a young society, facing
the new challenges associated with rapid growth and
the dynamic field of stem cell research. A formal strategic
planning session had just taken place. Attracting new
members was a major goal, and increasing the geo-
graphic span of members was desirable. A number of
committees had been established, but were not function-
ing on a year-round basis. Support dollars for the ISSCR
were a fraction of what they are today, with grants from
the Juvenile Diabetes Research Foundation and the U.S.
National Institutes of Health being used mainly to get the
ISSCR web site and scientific meeting series established.
The 2005 Annual Meeting was a watershed for the
ISSCR. Attendance had exploded from 600 participants
in Washington, D.C. in 2003 to 1400 attendees in Boston
in 2004, and with 2100 registered attendees in San Fran-
cisco, we had outgrown the typical hotel venue and grad-
uated to the need for a host city with good convention
facilities as well as plentiful hotel accommodations. We
have held relatively steady numbers for the past two years,
with 2200 registered attendees in Toronto, and over 1900
in Cairns, Australia this June.
The implications of this growth go well beyond Annual
Meeting facility needs. Increased attendance signified
the growing number of scientists around the world enter-
ing the field of stem cell biology and ultimately the devel-
opment of the field.
Oral and poster abstract submissions mushroomed to
a record 1375 this year. A formal abstract review process
had been established by 2005 that necessitated interna-
tional participation and rapid feedback, but the review
process, and the number of reviewers, has grown apace
with the increased submissions. The selection process
for travel awards involves a coordinated international
review process as well. The more than 700 requests for
travel stipends for the meeting in Cairns far exceeded our
available resources, although we made a record number
of 322 awards.
Predicting the growth of the Society—and of the Annual
Meeting—is an ongoing challenge for both the staff and
the leadership. What will our membership numbers look
like in five years? An equally important question relates
to who our constituencies will be. Who should they be?
What, specifically, will be the impact of increased recruit-
ment among translational, clinical, and industrial scien-
tists? What directions will the stem cell field take in the
next few years? These issues, and more, have a direct
bearing on how the staff, which is currently researching
sites for the 2011 Annual Meeting, plans to accommodate
the needs of the Society in the future.
As Executive Director, I must also be mindful that the
Society does not operate in a vacuum, and of the bur-
geoning number of stem cell meetings sponsored by otherorganizations that occur on an almost weekly basis
around the world. In 2005, we tended to view the annual
Keystone stem cell meeting as our closest counterpart.
Today, the list is an extended one. Our goal at the ISSCR
is to ensure that our Annual Meeting remains the most
comprehensive and highest quality stem cell meeting of
all, and that it becomes a ‘‘must attend’’ meeting for stem
cell scientists worldwide. To do this, we must continue
to serve the interests and needs of our membership.
Additionally, regional networks now exist in most areas
of the world where significant stem cell research takes
place. In 2005, many of these networks were limited in
their interactions with one another and with the ISSCR.
We are committed to the maintenance of links with these
regional networks, although many questions remain with
regard to how affiliation can be mutually beneficial, and
what type of synergies may exist that could be employed
to leverage the ISSCR’s mission and strategic goals.
With all of these changes in so short a period of time,
two things remain constant. First, the ISSCR has a staff
(Table 1) that has worked assiduously to realize the vision
of the Society since Leonard Zon, ISSCR’s founder, first
determined there was a need for a separate society of
stem cell researchers. While the staff oversees all admin-
istrative areas of the ISSCR, particular attention falls to
certain areas. The Annual Meeting represents a huge
commitment of time and talent. Michael Hagedorn works
closely with the Annual Meeting Program Committee to
develop the scheduling and scientific program, and Liz
Freyn is the Annual Meeting Director. In step with our
overall membership growth, our committees have grown
both in number and in the scope of their activities. Ryan
Detwiler was recruited this year as full-time administrator
for these committees. Science Editor Heather Rooke, PhD,
oversees scientific content of all ISSCR communications
and documents, in particular the web site. As Executive
Director, I have the primary responsibility to support and
coordinate the vision, leadership, and strategy efforts of
our Board of Directors. A privilege of being the Executive
Director is to have a clear view of the goals of each year’s
president and Executive Committee. The continuity of
my position allows me to be the keeper of the strategic
themes from year to year, and to implement communica-
tions and administrative structures that allow us to foster
new alliances.
The second constant is that the ISSCR remains the
only international membership society that embraces re-
searchers, clinicians, ethicists and policymakers, industry
representatives, civic leaders, and patient advocates. This
broad constituency bothmotivates and enables the ISSCR
to present a united voice for the continued global sup-
port of stem cell research and the exchange of scientific
information.
Dr. Douglas Melton, ISSCR founding Treasurer and
Board Member, said it best to the New York Times onCell Stem Cell 1, October 2007 ª2007 Elsevier Inc. 383
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it’s unlikely that one person or one lab will solve a problem
as big as degenerative diseases, which is what stem cell
researchers are trying to do.It takes a community of
people in an area to solve a big problem.’’
Mission and Goals Strategy—Then and Now
In early 2005, under the direction of Dr. Margaret Goodell,
the ISSCR Board participated in a formal strategic plan-
ning process to define its purpose as a Society. An outside
consulting firm was called upon, surveys were mailed to
the entire membership and analyzed, a group of interna-
tional stem cell leaders met for a planning session, and
a Strategic Planning Task Force was formed.
The Strategic Planning Task Force developed a mission
for the Society ‘‘to serve as the preeminent communica-
tion forum for the international community of stem cell sci-
entists.’’ Three goals were identified to accomplish this,
with the intention of making the ISSCR the most relevant
organization for stem cell scientists:
1. Promote fundamental knowledge and human health
through responsible discovery.
2. Be the preeminent, interdisciplinary global forum for
stem cell research and its application.
3. Serve as a balanced voice of public education and
advocacy for stem cell science worldwide.
The ISSCR mission and core goals remain the same
today. At the same time, the Strategic Planning Task
Force identified five key strategies for meeting those
goals. It’s important to evaluate where we stand in terms
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reveals progress, potential, and the need for reevaluation:
1. Increase opportunities for vigorous scientific
discourse, sharing, and a global exchange of ideas
The ISSCR continues to consider the Annual Meeting
a key responsibility. By joining with the Australian Stem
Cell Centre (ASCC) to sponsor the 5th ISSCR Annual
Meeting, the ISSCR highlighted an area of the world that
has a large and vibrant stem cell research community.
The ISSCR will avail itself of similar opportunities in the
UK and Europe when it partners with the UK National
Stem Cell Network (UKNSCN) in 2009.
The ISSCR values other partnership opportunities
within the context of the Annual Meetings. We hosted
the first meetings of the International Consortium of
Stem Cell Networks (ICSCN) and continue to look for
relevant synergies. The New York Stem Cell Foundation
(NYSCF) is a dedicated supporter of plenary sessions
and plays a key role in our travel award program for
Junior Investigators. The Stem Cell Network (Canada) was
most helpful in promoting the 4th ISSCR Annual Meet-
ing when it was held in Toronto. Individual consortium
members continue to play important roles in the Annual
Meeting and contribute to the valuable exchange of infor-
mation.
The ISSCR has benefited since its first year from a part-
nership with The Juvenile Diabetes Research Foundation
(JDRF) to maintain the ISSCRweb site that provides a bal-
anced voice for stem cell research. Two new partnerships
were added in 2006–2007 that enhance our ability to
provide accurate, timely, and peer-reviewed information.
In an affiliation agreement with John Wiley & Sons, the
ISSCR contributes to the development of the newly avail-
able Current Protocols in Stem Cell Biology. In addition,
we established a relationship with Cell Press in the launch
of Cell Stem Cell. Current Protocols in Stem Cell Biology
and Cell Stem Cell provide additional tools to the stem
cell community and complement our web site as a forum
for communication to our membership.
Other opportunities for exchanges of information are
being explored. ISSCR leaders met with representatives
of the Human Proteome Organisation (HUPO) while in
Cairns and agreed to a new initiative, Proteome Biology
of Stem Cells, to provide a world-wide platform for inves-
tigators in stem cell proteomics.
2. Promote high-quality, responsible, ethical
research and ambitious but cautious clinical
translation
In the President’s Note last month, Dr. George Q. Daley
described some of the very active efforts taking place
within committees. During the last year the ISSCR pub-
lished the ISSCR Guidelines for the Conduct of Human
Embryonic Stem Cell Research with the express purpose
to provide a uniform set of principles and an ethical frame-
work that we hope stem cell scientists worldwide will
embrace. Our Ethics and Public Policy Committee,
chaired by Dr. Insoo Hyun, extended the Guidelines in
the area of chimera research, and in the ISSCR pages
of the August issue of this journal, printed an initial
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chimera studies, an excellent resource for research over-
sight bodies.
In collaboration with the International StemCell Initiative
(ISCI) of the International Stem Cell Forum, the Standards
Committee, which helped formulate the guidelines perti-
nent to banking and characterization of human ES cells,
will participate in the development of a world-wide registry
of human ES cells. This effort will involve Peter Andrews,
a key leader of the ISCI and cochair of the Standards
Committee.
3. Ensure the strength and vitality
of the field by attracting the best minds
and preparing the next generation of scientists;
and advocating the increase of funds available
for research and coordinating distribution of funds
to promising research
The ISSCR is a young organization, but we have already
grown to over 2000 members, and our membership in-
cludes many of the world’s leading stem cell scientists.
Our Annual Meeting has become the preeminent interna-
tional forum for the presentation of stem cell science.
The next generation of scientists, referred to within the
ISSCR as Junior Investigators, represent 34%of the entire
membership, and 43% of this year’s Annual Meeting at-
tendance. The Junior Investigator Committee, chaired by
Dr. Kelly McNagny, organizes dedicated career-building
events at the Annual Meeting, including The ‘‘So You
Want to Start Your Own Lab’’ networking hour. As part
of its commitment to preparing the next generation of sci-
entists, Junior Investigators are a priority for ISSCR travel
fellowships. The New York Stem Cell Foundation (NYSCF)
has joined with the ISSCR since 2005 to provide travel
award stipends specifically to Junior Investigators from
all regions of the world.
In spite of these advancements, there are still issues
that need to be addressed. In some circles, for instance,
the ISSCR is perceived as a U.S. or North American orga-
nization, perhaps a byproduct of its early roots. The lead-
ership has listened to these criticisms, as well as to newer
ones from fresh voices wanting to be heard. We have
worked with each president, with the International Com-
mittee chair, Douglas Sipp, and with each working com-
mittee chair over the past three years to strike an appropri-
ate geographic balance on both committee participation
and within the Board of Directors.
Robert Klein, of the California Institute for Regenerative
Medicine (CIRM), suggested, and theCIRM funded, a spe-
cial panel session at this year’s meeting titled New Fund-
ing Paradigms in Stem Cell Research. Mr. Klein, the driv-
ing force behind the CIRM, has helped us to formulate
the plan for the ISSCR Global Advisory Council and has
accepted the role as a founding member. The mission of
the Global Advisory Council will be to serve as an ISSCR
‘‘think tank’’ for global strategies on how best to promote
stem cell research and clinical applications, aswell as new
funding paradigms through coordinated public education,
effective public relations, and governmental and philan-
thropic support.4. Create an effective forum for public education
and balanced advocacy for stem cell science
The huge possibilities for stem cells as discovery tools and
therapies in themselves have not just grabbed the imagi-
nations of scientists but people from all walks of life, and
the media follows stem cell research and the politics
that surround it very closely. The ISSCR feels very strongly
that expressing the excitement felt in the field balanced
with realistic expectations of the hurdles faced in bringing
the science from the bench to the clinic is critical for sus-
taining the interest in and support of stem cell research.
The ISSCR web site remains a key medium for the pre-
sentation of information, with resources on basic biology,
bioethics, recent research findings, and international leg-
islation. The ISSCR maintains an active Public Education
Committee, who in addition to working with the science
editor to generate thematerial included on the public inter-
face on its web site, provides support and advice to other
groups as they develop tools for public education. The
Public Education Committee also organizes a public fo-
rum alongside the Annual Meeting each year, bringing in
speakers and panelists of well-known stem cell biologists,
bioethicists, and legislators to discuss the progress and
issues pertinent to the stem cell field. In 2008, the forum
will be extended to include a half-day program with short
courses on stem cell biology for teachers, press, and inter-
ested individuals from local schools.
The Government Affairs Committee of the ISSCR pro-
vides a mechanism to reach out to local governments
around the world, lending an international voice to support
scientists in their endeavors to promote research in their
own areas. Practical support through the development
of internationally relevant guidelines and policies for the
practice of stem cell biology is a further aspect of advo-
cacy. Looking forward, the ISSCR will convene a task
force to provide recommendations on the regulation and
oversight of clinical translation of stem cell research.
5. Increase ISSCR’s capacity to address itsmission
by implementing governance structures
and processes that support responsiveness
to and engagement of global constituents
in decision-making processes; and identify
and refine delivery mechanisms for the global
exchange of information, ideas, and education
Given its robust growth and the success with which the
Society has met its initial goals to become the primary
global voice for the stem cell research community, there
is now a desire to broaden the membership and leader-
ship resources available to the ISSCR to include the busi-
ness, civic, and philanthropic leaders, and use their exper-
tise and insights to the benefit of stem cell communities.
With this goal in mind, the ISSCR has established a Global
Advisory Council comprised of leading international busi-
ness leaders and policymakers to advise us on the strate-
gic direction of our Society, and to help us forge a plan to
ensure the financial health of the Society. The Council will
meet annually in a one-day Global Forum that will bring to-
gether top thinkers from the public and private sector with
members of the stem cell research community to developCell Stem Cell 1, October 2007 ª2007 Elsevier Inc. 385
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regenerative medicine.
The Global Forum initiative is one more indication of the
ISSCR’s continuingmaturation and growing influence. We
are at a stage of development where alliances with other
key policy-setting organizations are a necessity, and
ISSCR leaders will explore the potential for relationships
with other groups such as the International Stem Cell
Forum (ISCF).
Exciting questions remain to be resolved: What goals
should we set looking forward? How canwe best drive for-386 Cell Stem Cell 1, October 2007 ª2007 Elsevier Inc.ward on translational and clinical science while retaining
our strong base in basic science? How can the ISSCR
work with Scientific Directors in corporations to create
mutually beneficial synergies? How can ISSCR partner
with regional, national, and international patient advocacy
groups and foundations to move toward disease-driven
research goals? How do we use our international voice
more proactively in governmental issues? I look forward
to working with the leadership and staff to address the
Society’s increasingly sophisticated requirements with
creative responses.
Nancy Witty
Executive Director, ISSCR
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